Dev Nishanth
Department of Medicine, ESIC Medical College, Faridabad, India.
Maedica (Bucur). 2018 Jun;13(2):155-158. doi: 10.26574/maedica.2018.13.2.155.
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare and challenging entity which can be life threatening and is associated with many medications. Yet, Glimepiride has never been reported as offending agent. We present here the first case of Glimepiride induced DRESS syndrome. A 40-year-old male with type 2 diabetes mellitus was prescribed Glimepiride. One month later, the patient presented with diffuse rash, fever, swelling of extremities and jaundice. The leucocyte count at presentation was 22,000 cells/microL and absolute eosinophil count 5,400 cells/microL, with no atypical cells on peripheral blood smear. Skin biopsy was non-specific. Other sources of infections such as parasitic infections, HIV, viral hepatitis were ruled out. Patient improved symptomatically on discontinuation of Glimepiride and improved dramatically on steroids. DRESS syndrome as a possible complication of Glimepiride should be considered by clinicians. According to RegiSCAR, our case was categorized as definitive with score of 7. In the vast majority of reported cases, they are classified as probable cases.
药物超敏反应伴嗜酸性粒细胞增多和全身症状(DRESS)综合征是一种罕见且具有挑战性的病症,可能危及生命,与多种药物有关。然而,格列美脲从未被报道为致病药物。我们在此报告首例格列美脲诱发的DRESS综合征病例。一名40岁的2型糖尿病男性患者服用了格列美脲。一个月后,患者出现弥漫性皮疹、发热、四肢肿胀和黄疸。就诊时白细胞计数为22,000个/微升,绝对嗜酸性粒细胞计数为5,400个/微升,外周血涂片未见异型细胞。皮肤活检无特异性。排除了其他感染源,如寄生虫感染、艾滋病毒、病毒性肝炎。停用格列美脲后患者症状改善,使用类固醇后症状显著改善。临床医生应考虑DRESS综合征作为格列美脲可能的并发症。根据RegiSCAR标准,我们的病例被归类为确诊病例,评分为7分。在绝大多数报道的病例中,它们被归类为可能病例。